000919 金陵药业
2026/09 - 九个月
人民币(K¥)
2025/12
人民币(K¥)
2024/12
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
经营活动产生之现金流量净额237,066174,209154,191212,025260,591
投资活动产生之现金流量净额(314,822)(309,406)(717,705)(449,892)(221,115)
筹资活动产生之现金流量净额(67,315)(85,076)806,418(43,548)(46,265)
汇率变动对现金及现金等价物的影响(63)8371980
现金及现金等价物净增加/(减少)(145,134)(220,264)242,941(281,396)(6,709)
期初现金及现金等价物余额1,361,1041,581,3681,338,4271,619,8241,481,593
期末现金及现金等价物余额1,215,9691,361,1041,581,3681,338,4271,474,883